Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Cash flows from operating activities:
Net loss	$ (1,004,251)	$ (726,306)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,459	1,824
Stock option compensation expense	16,069	14,328
Share-based compensation - common stock	2,125	$ 4,038
Common stock and warrants issued to consultants	182,600
Debt discount amortization	$ 49,720	$ 61,364
Noncash finance charges		18,434
Unrealized gain on derivative instruments		$ (14,232)
Loss on conversion of notes	$ 2,588
Loss on settlement of note and warrant		$ 132,301
Changes in assets and liabilities:
Receivables	$ (1,072)	57,013
Prepaid expenses and other current assets	$ 73,466	17,072
Inventory		30,000
Accounts payable, accrued expenses and other liabilities	$ 385,457	178,694
Deferred revenue	(5,905)	13,287
Net cash used in operating activities	$ (294,744)	(212,183)
Cash flows from investing activities:
Purchase of property and equipment		(3,078)
Cash used in investing activities		(3,078)
Cash flows from financing activities:
Proceeds from notes payable	$ 257,000	120,000
Repayment of note and warrant settlement	(42,500)	(118,000)
Proceeds from common stock and warrants	75,000	500,000
Net cash provided by financing activities	289,500	502,000
Net increase (decrease) in cash	(5,244)	286,739
Cash at beginning of period	5,745	57,009
Cash at end of period	$ 501	$ 343,748